What is Joint Active Systems?
Joint Active Systems operates at the intersection of orthopedics and rehabilitation technology, specializing in the development of advanced range of motion devices. By providing dynamic and static progressive stretch braces for critical joints including the shoulder, knee, and elbow, the company addresses the complex needs of patients suffering from limited mobility and upper extremity conditions. Their business model is built upon a foundation of clinical evidence, targeting a diverse ecosystem of healthcare professionals, insurance adjusters, and patients. Through a commitment to precise customization and measurable recovery metrics, Joint Active Systems has established itself as a critical provider in the functional rehabilitation market, effectively bridging the gap between surgical intervention and full physical recovery.
How much funding has Joint Active Systems raised?
Joint Active Systems has raised a total of $2.1M across 2 funding rounds:
Debt
$1M
Debt
$1.1M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.1M led by PPP
Key Investors in Joint Active Systems
PPP
Public-Private Partnership
What's next for Joint Active Systems?
With the recent influx of capital, Joint Active Systems is well-positioned to accelerate its enterprise-level expansion and deepen its penetration into the global orthopedic market. The strategic allocation of these funds will likely focus on enhancing the research and development pipeline for next-generation bracing solutions and expanding the company's clinical support infrastructure. As the healthcare industry continues to prioritize value-based care and patient-centric recovery models, Joint Active Systems is poised to leverage its technological edge to capture additional market share. Future growth will likely be driven by the integration of data-driven monitoring tools into their existing product suite, further cementing their role as a leader in therapeutic mobility solutions.
See full Joint Active Systems company page
